Company News: Page (1) of 1 - 10/02/17 Email this story to a friend. email article Print this page (Article printing at page facebook

Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product

-- Drug-device combination therapy for inhaled pharmaceutical-grade xenon gas under investigation to lessen brain damage, improve survival and function in patients suffering cardiac arrest ---- FDA Sp... (October 02, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Manufacturing,Sales,Distribution,Manufacturing/Production,Insurance,Shipping & Receiving,Manufacturing,Sales & Marketing,Internet,Business Issues,Law & Regulations,Management,Finance/Accounting,Sales,Finance/Accounting,Sales,Pro AV,Management,Presentors,Business,Law,Business Issues,Presentation,Channel/Distribution,People,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved